Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CurcumaSlim is a patented proprietary dietary supplement ingredient developed by Iovate Health Sciences International, the manufacturer of Hydroxycut weight-loss products. It is a combination of two active components: curcumin extract, derived from turmeric (*Curcuma longa*), and alpha lipoic acid (ALA). The formulation is designed to support weight management by facilitating the conversion of glucose into cellular energy. It serves as a key ingredient in Hydroxycut Ultra Lean, where it is combined with other substances such as vitamins C and B, and natural coffee extract. Clinical studies have demonstrated that the CurcumaSlim combination can lead to significant weight loss when used in conjunction with a reduced-calorie diet and a walking program. As a nutraceutical blend, it does not target a specific pharmaceutical receptor but rather influences metabolic pathways related to energy production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CurcumaSlim.